exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
Published 1 year ago • 41 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
3:04
applying molecular understanding of dlbcl to management strategies
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
1:53
discussion of the two biologies of dlbcl - the gcb and abc subtype and potential targeted therapies
-
1:56
the need for new treatment strategies for patients with dlbcl
-
1:52
an insight into the optimal management of patients with dlbcl
-
15:28
dlbclの基礎
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
29:38
dlbcl treatment approaches: what you need to know
-
1:45
improving the frontline treatment of dlbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
5:53
14 molecular biological perspective on interleukin-11 inhibition and healthspan extension
-
1:33
the difficulties of mrd detection in dlbcl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
4:01
first- and second-line treatment in dlbcl
-
0:43
the unmet need in dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
20:48
current upfront management of dlbcl
-
1:34
the standard of care for dlbcl and double-hit lymphoma
-
0:55
dlbcl research to watch
-
1:32
management and outcomes of elderly patients with lbcl
-
1:34
molecular-guided treatment of b-cell lymphomas